These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1593 related articles for article (PubMed ID: 24655295)

  • 1. Immunology of psoriasis.
    Lowes MA; Suárez-Fariñas M; Krueger JG
    Annu Rev Immunol; 2014; 32():227-55. PubMed ID: 24655295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses in psoriasis and psoriatic arthritis.
    Diani M; Altomare G; Reali E
    Autoimmun Rev; 2015 Apr; 14(4):286-92. PubMed ID: 25445403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
    Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I
    Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
    Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
    Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.
    Zaba LC; Fuentes-Duculan J; Eungdamrong NJ; Abello MV; Novitskaya I; Pierson KC; Gonzalez J; Krueger JG; Lowes MA
    J Invest Dermatol; 2009 Jan; 129(1):79-88. PubMed ID: 18633443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
    Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
    Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.
    Nograles KE; Zaba LC; Guttman-Yassky E; Fuentes-Duculan J; Suárez-Fariñas M; Cardinale I; Khatcherian A; Gonzalez J; Pierson KC; White TR; Pensabene C; Coats I; Novitskaya I; Lowes MA; Krueger JG
    Br J Dermatol; 2008 Nov; 159(5):1092-102. PubMed ID: 18684158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine network in psoriasis revisited.
    Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
    Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang H; Ren C; Liu Q; Wang Q; Wang D
    Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.
    Sønder SU; Paun A; Ha HL; Johnson PF; Siebenlist U
    J Immunol; 2012 Jun; 188(12):5906-14. PubMed ID: 22581863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis.
    Volpe E; Pattarini L; Martinez-Cingolani C; Meller S; Donnadieu MH; Bogiatzi SI; Fernandez MI; Touzot M; Bichet JC; Reyal F; Paronetto MP; Chiricozzi A; Chimenti S; Nasorri F; Cavani A; Kislat A; Homey B; Soumelis V
    J Allergy Clin Immunol; 2014 Aug; 134(2):373-81. PubMed ID: 24910175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.